Open Beta
MetriLume

US marketsSKIN

SEC-sourced researchBeta

SKIN

SkinHealth Systems Inc.

Company comparison ↗

Data passport

CIK
0001818093
Exchange
Nasdaq
Business activity
— · SIC 3841
Financial inputs
6/6
Filing date
Sep 28, 2026
SEC registry record
Operating company

Annual financial history

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table. Exact amounts and source periods: December 2023: 397,991,000.0000 USD; December 2024: 334,294,000.0000 USD; December 2025: 300,790,000.0000 USD398M USD0 USD0December 2023December 2024December 2025
SKIN · Exact amounts and source periods · USD
Period endRevenueFiling date
December 2023397,991,000.0000Mar 12, 2026
December 2024334,294,000.0000Mar 12, 2026
December 2025300,790,000.0000Mar 12, 2026

Annual periods · USD

Period endRevenueNet incomeOperating cash flowTotal assetsTotal liabilitiesFiling date
December 2025300,790,000.0000-9,519,000.000037,485,000.0000499,803,000.0000438,747,000.0000Mar 12, 2026
December 2024334,294,000.0000-29,098,000.000016,134,000.0000685,683,000.0000633,880,000.0000Mar 12, 2026
December 2023397,991,000.0000-100,116,000.000021,750,000.0000——Mar 12, 2026

Financial inputs behind the calculation

Financial inputsUSDPeriod endFiling dateForm
RevenueRevenueFromContractWithCustomerExcludingAssessedTax$300.79MDecember 2025Mar 12, 202610-K
Previous period revenueRevenueFromContractWithCustomerExcludingAssessedTax$334.29MDecember 2024Mar 12, 202610-K
Net incomeNetIncomeLoss-$9.52MDecember 2025Mar 12, 202610-K
Operating cash flowNetCashProvidedByUsedInOperatingActivities$37.49MDecember 2025Mar 12, 202610-K
Total assetsAssets$499.8MDecember 2025Mar 12, 202610-K
Total liabilitiesLiabilities$438.75MDecember 2025Mar 12, 202610-K

New filings

Explore methodology ↗